239 related articles for article (PubMed ID: 9513693)
41. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
Karakiewicz PI; Benayoun S; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Marberger MJ; Shariat SF
BJU Int; 2006 May; 97(5):997-1001. PubMed ID: 16542342
[TBL] [Abstract][Full Text] [Related]
42. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms.
Ramos D; Ruiz A; Morell L; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
Anal Quant Cytol Histol; 2004 Oct; 26(5):285-94. PubMed ID: 15560535
[TBL] [Abstract][Full Text] [Related]
44. Transitional cell carcinoma of the renal pelvis the diagnostic role of pelvic washings.
Witte D; Truong LD; Ramzy I
Am J Clin Pathol; 2002 Mar; 117(3):444-50. PubMed ID: 11888084
[TBL] [Abstract][Full Text] [Related]
45. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
[TBL] [Abstract][Full Text] [Related]
46. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
[TBL] [Abstract][Full Text] [Related]
47. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma.
Straub J; Strittmatter F; Karl A; Stief CG; Tritschler S
Urol Oncol; 2013 Oct; 31(7):1166-70. PubMed ID: 22300757
[TBL] [Abstract][Full Text] [Related]
48. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
49. Low-grade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep.
Xin W; Raab SS; Michael CW
Diagn Cytopathol; 2003 Sep; 29(3):125-9. PubMed ID: 12951678
[TBL] [Abstract][Full Text] [Related]
50. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.
Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT
Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971
[TBL] [Abstract][Full Text] [Related]
51. Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis.
Veltri RW; Marlow C; Khan MA; Miller MC; Epstein JI; Partin AW
Prostate; 2007 Aug; 67(11):1202-10. PubMed ID: 17525934
[TBL] [Abstract][Full Text] [Related]
52. Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium.
Pycha A; Mian C; Hofbauer J; Brössner C; Haitel A; Wiener H; Marberger M
Urology; 1999 Jan; 53(1):92-7. PubMed ID: 9886595
[TBL] [Abstract][Full Text] [Related]
53. Grading of transitional cell bladder carcinoma by image analysis of histological sections.
Jarkrans T; Vasko J; Bengtsson E; Choi HK; Malmström PU; Wester K; Busch C
Anal Cell Pathol; 1995 Mar; 8(2):135-58. PubMed ID: 7786812
[TBL] [Abstract][Full Text] [Related]
54. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
[TBL] [Abstract][Full Text] [Related]
55. Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladder.
van der Poel HG; Boon ME; Kok LP; van der Meulen EA; van Caubergh RD; de Bruijn WC; Debruyne FM
Anal Quant Cytol Histol; 1991 Oct; 13(5):307-15. PubMed ID: 1801828
[TBL] [Abstract][Full Text] [Related]
56. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology: A Correlative Study of 124 Cases.
Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F
Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983
[TBL] [Abstract][Full Text] [Related]
57. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
58. Use of cytomorphometry and cytology in the diagnosis of transitional-cell carcinoma of the upper urinary tract.
Seldenrijk CA; Verheggen WJ; Veldhuizen RW; Blok AP; Ooms EC
Acta Cytol; 1987; 31(2):137-42. PubMed ID: 3469846
[TBL] [Abstract][Full Text] [Related]
59. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine.
Renshaw AA; Nappi D; Weinberg DS
Acta Cytol; 1996; 40(4):676-82. PubMed ID: 8693885
[TBL] [Abstract][Full Text] [Related]
60. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
